 the regulatory science to advance precision medicine forum was held to identify and address the challenges associated with the implementation of new genetic testing technologies. The forum found that there are many regulatory science gaps that must be addressed before these technologies can be used effectively in clinical practice. These include the lack of standardization of complex tests, preclinical issues, establishing clinical validity and utility, pharmacogenomics considerations, and knowledge gaps.